• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兔肌肉内持续释放的游离庆大霉素和脂质体包裹庆大霉素的评估。

Evaluation of free and liposome-encapsulated gentamycin for intramuscular sustained release in rabbits.

作者信息

Cabanes A, Reig F, Garcia-Anton J M, Arboix M

机构信息

Department of Peptides, CID, CSIC, Barcelona, Spain.

出版信息

Res Vet Sci. 1998 May-Jun;64(3):213-7. doi: 10.1016/s0034-5288(98)90128-x.

DOI:10.1016/s0034-5288(98)90128-x
PMID:9690606
Abstract

Gentamycin sulphate (GS) and gentamycin oleate (GO) were encapsulated in liposomes composed of phosphatidylcholine (HPC) and cholesterol (CHOL) (molar ratio 7:7:2 and 5:5:1, respectively), and were administered via intramuscular injection to rabbits, to evaluate their potential use as sustained release formulations. Five groups of five animals each were used for the pharmacokinetic study, and treatments were established as follows: 3 mg kg(-1) of GS i.v., 3 mg kg(-1) of GS i.m., 3 mg kg(-1) of liposome-containing gentamycin sulphate (LGS) i.m., 3 mg kg(-1) of GO i.m., and 3 mg kg(-1) of liposome-containing gentamycin oleate (LGO) i.m. Gentamycin plasma concentrations after i.m. administration of LGS were extremely low compared with those obtained after the i.m. administration of GS; the peak plasma concentration (Cmax) showed an eight-fold decrease with LGS, and the area under the concentration-time curve (AUC) was four-fold lower for the liposomal form. The apparent elimination half-life estimated after administration of LGS showed a three-fold increase compared with values calculated for free GS. After the administration of the same dose of LGO, Cmax obtained showed a 2.5-fold decrease in relation to peak concentrations of free GO, and the apparent beta-half life of encapsulated GO showed a three-fold increase compared with i.m. GO. Large-size liposomes containing gentamycin administered i.m. to rabbits gave sustained drug release from the injection site, providing prolonged plasma concentrations of the drug in the body.

摘要

将硫酸庆大霉素(GS)和油酸庆大霉素(GO)包裹于由磷脂酰胆碱(HPC)和胆固醇(CHOL)组成的脂质体中(摩尔比分别为7:7:2和5:5:1),通过肌肉注射给予兔子,以评估它们作为缓释制剂的潜在用途。每组五只动物,共五组用于药代动力学研究,处理方式如下:静脉注射3mg kg⁻¹的GS,肌肉注射3mg kg⁻¹的GS,肌肉注射3mg kg⁻¹含硫酸庆大霉素的脂质体(LGS),肌肉注射3mg kg⁻¹的GO,以及肌肉注射3mg kg⁻¹含油酸庆大霉素的脂质体(LGO)。与肌肉注射GS后相比,肌肉注射LGS后庆大霉素的血浆浓度极低;血浆峰浓度(Cmax)显示LGS降低了八倍,脂质体形式的浓度-时间曲线下面积(AUC)降低了四倍。注射LGS后估计的表观消除半衰期与游离GS计算值相比增加了三倍。给予相同剂量的LGO后,获得的Cmax相对于游离GO的峰浓度降低了2.5倍,包封的GO的表观β半衰期与肌肉注射GO相比增加了三倍。向兔子肌肉注射含庆大霉素的大尺寸脂质体可使药物从注射部位持续释放,从而使药物在体内的血浆浓度延长。

相似文献

1
Evaluation of free and liposome-encapsulated gentamycin for intramuscular sustained release in rabbits.兔肌肉内持续释放的游离庆大霉素和脂质体包裹庆大霉素的评估。
Res Vet Sci. 1998 May-Jun;64(3):213-7. doi: 10.1016/s0034-5288(98)90128-x.
2
Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits.兔肌肉注射脂质体包封的恩诺沙星后的缓释效果。
Am J Vet Res. 1995 Nov;56(11):1498-501.
3
Intravitreal liposome-encapsulated gentamicin in a rabbit model. Prolonged therapeutic levels.兔模型中玻璃体内脂质体包裹庆大霉素。延长治疗水平。
Invest Ophthalmol Vis Sci. 1986 Jul;27(7):1103-6.
4
Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration.小单层低清除率阿米卡星脂质体制剂血管外给药后的生物利用度。
J Drug Target. 1999;6(6):415-26. doi: 10.3109/10611869908996848.
5
Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.脂质体包裹长春新碱给药后的脂质体和非脂质体药物药代动力学及其对药物组织分布特性的影响。
J Pharmacol Exp Ther. 2001 Sep;298(3):1206-12.
6
[Use of aminoglycoside antibiotic gentamycin in extremely premature infants--administration schedule and suggested dosage based on pharmacokinetic studies in plasma].[氨基糖苷类抗生素庆大霉素在极早产儿中的应用——基于血浆药代动力学研究的给药方案及建议剂量]
Akush Ginekol (Sofiia). 2006;45(3):30-3.
7
Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity.脂质体复合多孔 β-TCP 支架的制备、表征及抗生物膜活性
Drug Deliv. 2010 Aug;17(6):391-8. doi: 10.3109/10717541003762870.
8
Pharmacokinetics of a high dose of gentamicin administered intravenously or intramuscularly to horses.静脉注射或肌肉注射高剂量庆大霉素给马后的药代动力学
J Am Vet Med Assoc. 1998 Oct 1;213(7):1007-11.
9
Evaluation of soluble Bioadhesive Ophthalmic Drug Inserts (BODI) for prolonged release of gentamicin: lachrymal pharmacokinetics and ocular tolerance.用于庆大霉素长效释放的可溶性生物黏附眼用药物插入剂(BODI)的评估:泪液药代动力学和眼部耐受性。
J Ocul Pharmacol Ther. 1998 Jun;14(3):263-72. doi: 10.1089/jop.1998.14.263.
10
Pharmacokinetics of gentamicin following single-dose parenteral administration to goats.庆大霉素单次非肠道给药后在山羊体内的药代动力学。
Br Vet J. 1995 Jul-Aug;151(4):453-8. doi: 10.1016/s0007-1935(95)80134-0.

引用本文的文献

1
Niosome-encapsulated gentamicin for ophthalmic controlled delivery.用于眼科控释的脂质体包裹庆大霉素
AAPS PharmSciTech. 2008;9(3):740-7. doi: 10.1208/s12249-008-9105-1. Epub 2008 Jun 18.